BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 17920054)

  • 1. Carbohydrate-deficient transferrin (CDT) as a biochemical tool for the screening of congenital disorders of glycosylation (CDGs).
    Biffi S; Tamaro G; Bortot B; Zamberlan S; Severini GM; Carrozzi M
    Clin Biochem; 2007 Dec; 40(18):1431-4. PubMed ID: 17920054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Argininosuccinate lyase deficiency (ASL) and carbohydrate-deficient transferrin (CDT): experience with four independent CDT analysis methods--misleading results given by the %CDT TIA assay.
    Arndt T; Gressner A; Herwig J; Meier U; Sewell AC
    Clin Chim Acta; 2006 Nov; 373(1-2):117-20. PubMed ID: 16808909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening using serum percentage of carbohydrate-deficient transferrin for congenital disorders of glycosylation in children with suspected metabolic disease.
    Pérez-Cerdá C; Quelhas D; Vega AI; Ecay J; Vilarinho L; Ugarte M
    Clin Chem; 2008 Jan; 54(1):93-100. PubMed ID: 18024528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison between high performance liquid chromatography and capillary zone electrophoresis for the diagnosis of congenital disorders of glycosylation.
    Quintana E; Montero R; Casado M; Navarro-Sastre A; Vilaseca MA; Briones P; Artuch R
    J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Aug; 877(24):2513-8. PubMed ID: 19608465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Personal experience with the application of carbohydrate-deficient transferrin (CDT) assays to the detection of congenital disorders of glycosylation.
    Colomé C; Ferrer I; Artuch R; Vilaseca MA; Pineda M; Briones P
    Clin Chem Lab Med; 2000 Oct; 38(10):965-9. PubMed ID: 11140630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Forensic analysis of carbohydrate-deficient transferrin (CDT): implementation of a screening and confirmatory analysis concept is hampered by the lack of CDT isoform standards.
    Arndt T; Keller T
    Forensic Sci Int; 2004 Nov; 146(1):9-16. PubMed ID: 15485716
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is there an analytical or diagnostic advantage from including trisialo transferrin into the fraction of carbohydrate-deficient transferrin? Lessons from a comparison of two commercial turbidimetric immunoassays with the carbohydrate-deficient transferrin determination by high-performance liquid chromatography.
    Lipkowski M; Dibbelt L; Seyfarth M
    Clin Biochem; 2000 Nov; 33(8):635-41. PubMed ID: 11166010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of alcohol use, ethnicity, age, gender, BMI and smoking on the serum transferrin glycoform pattern: implications for use of carbohydrate-deficient transferrin (CDT) as alcohol biomarker.
    Bergström JP; Helander A
    Clin Chim Acta; 2008 Feb; 388(1-2):59-67. PubMed ID: 17980706
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improved capillary electrophoresis method for the determination of carbohydrate-deficient transferrin in patient sera.
    Lanz C; Kuhn M; Deiss V; Thormann W
    Electrophoresis; 2004 Jul; 25(14):2309-18. PubMed ID: 15274013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determination of carbohydrate-deficient transferrin in human serum using the Bio-Rad %CDT by HPLC test.
    Helander A; Bergström JP
    Clin Chim Acta; 2006 Sep; 371(1-2):187-90. PubMed ID: 16698004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High prevalence of increased trisialotransferrin concentrations in patients with anorexia nervosa: implications for determination of carbohydrate-deficient transferrin.
    Arndt T; Erkens M; Holtkamp K; Keller T; Gressner AM
    Clin Chim Acta; 2007 Apr; 379(1-2):150-3. PubMed ID: 17291470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HPLC and mass spectrometric characterization of a candidate reference material for the alcohol biomarker carbohydrate-deficient transferrin (CDT).
    Oberrauch W; Bergman AC; Helander A
    Clin Chim Acta; 2008 Sep; 395(1-2):142-5. PubMed ID: 18590715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Asymptomatic phosphomannose isomerase deficiency (MPI-CDG) initially mistaken for excessive alcohol consumption.
    Helander A; Jaeken J; Matthijs G; Eggertsen G
    Clin Chim Acta; 2014 Apr; 431():15-8. PubMed ID: 24508628
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new capillary zone electrophoresis method for the screening of congenital disorders of glycosylation (CDG).
    Parente F; Ah Mew N; Jaeken J; Gilfix BM
    Clin Chim Acta; 2010 Jan; 411(1-2):64-6. PubMed ID: 19840782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Congenital disorder of glycosylation Ia: new differentially expressed proteins identified by 2-DE.
    Richard E; Vega AI; Pérez B; Roche C; Velázquez R; Ugarte M; Pérez-Cerdá C
    Biochem Biophys Res Commun; 2009 Feb; 379(2):267-71. PubMed ID: 19101518
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Forensic analysis of carbohydrate-deficient transferrin (CDT) by HPLC--statistics and extreme CDT values.
    Arndt T; Guessregen B; Hallermann D; Nauck M; Terjung D; Weckesser H
    Forensic Sci Int; 2008 Feb; 175(1):27-30. PubMed ID: 17560061
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening for congenital disorders of glycosylation (CDG): transferrin HPLC versus isoelectric focusing (IEF).
    Quintana E; Navarro-Sastre A; Hernández-Pérez JM; García-Villoria J; Montero R; Artuch R; Ribes A; Briones P
    Clin Biochem; 2009 Mar; 42(4-5):408-15. PubMed ID: 19146845
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interference of transferrin isoform types with carbohydrate-deficient transferrin quantification in the identification of alcohol abuse.
    Helander A; Eriksson G; Stibler H; Jeppsson JO
    Clin Chem; 2001; 47(7):1225-33. PubMed ID: 11427453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and multicenter evaluation of the N latex CDT direct immunonephelometric assay for serum carbohydrate-deficient transferrin.
    Delanghe JR; Helander A; Wielders JP; Pekelharing JM; Roth HJ; Schellenberg F; Born C; Yagmur E; Gentzer W; Althaus H
    Clin Chem; 2007 Jun; 53(6):1115-21. PubMed ID: 17412797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary biliary cirrhosis is not a clinical condition for increased carbohydrate-deficient transferrin: experience with four independent CDT analysis methods.
    Arndt T; Meier U; Nauck M; Gressner AM
    Clin Chim Acta; 2006 Oct; 372(1-2):184-7. PubMed ID: 16790238
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.